11/7
03:37 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
11/7
03:37 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
11/7
12:49 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/28
12:38 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/28
12:38 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/28
08:47 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/28
08:47 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/28
08:01 am
rvmd
Rating for RVMD
Medium
Report
Rating for RVMD
10/28
08:01 am
rvmd
Rating for RVMD
Medium
Report
Rating for RVMD
10/25
03:52 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/25
03:52 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/24
08:08 am
rvmd
Revolution Medicines, Inc. (NASDAQ: RVMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
Medium
Report
Revolution Medicines, Inc. (NASDAQ: RVMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
10/24
05:55 am
rvmd
Rating for RVMD
Medium
Report
Rating for RVMD
10/24
05:55 am
rvmd
Rating for RVMD
Medium
Report
Rating for RVMD
10/7
08:17 am
rvmd
Revolution Medicines, Inc. (NASDAQ: RVMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
Low
Report
Revolution Medicines, Inc. (NASDAQ: RVMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
10/7
05:28 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/7
05:28 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
9/27
02:07 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
9/27
02:07 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD